Research status of irisquinone in antitumor therapy
10.13699/j.cnki.1001-6821.2017.08.023
- VernacularTitle:马蔺子素在抗肿瘤方面的研究现状
- Author:
Ya-Jing LI
1
;
Fu-Geng ZHANG
Author Information
1. 天津医科大学肿瘤医院药学部
- Keywords:
irisquinone;
lung cancer;
tumor;
sensitization agent
- From:
The Chinese Journal of Clinical Pharmacology
2017;33(8):757-759
- CountryChina
- Language:Chinese
-
Abstract:
Irisquinone is extracted from marin son quinone compounds,it has the advantages of high efficiency low toxicity,such as lung cancer,head and neck cancer has good curative effect.Irisquinone is in view of the lack of oxygen to cells of radiotherapy sensitization agent,can also accelerate the lesions of narrow,increase the rate of tumor all disappear,reduce tumor recurrence rate,improve patient surial.This paper aims to research summary of the chemical components and pharmacological effects,to enlarge the indications of the drug,"old drugs with new" provided the scientific basis.
